Carregant...
Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis
There is increasing appreciation of the important role of B cells in many autoimmune diseases and consequently, increasing interest in treating these disorders through B cell-depletion therapy with rituximab, an anti-CD20 monoclonal antibody. Yet, precisely how this and related drugs exert their the...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
National Academy of Sciences
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2842072/ https://ncbi.nlm.nih.gov/pubmed/20176942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1001074107 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|